Hypogonadism Treatment Market : Opportunities, Demand and Forecasts, 2017-2025 – Rapid News Network
Posted: September 20, 2019 at 2:46 am
Hypogonadism is defined as hormonal disorder in which the glands (gonads & ovaries) produce little or no hormones causing its deficiency in the body. Hypogonadism in males refers to deficiency of testosterone due to dysfunction of either of the testes. Female hypogonadism refers to deficiency of estrogen or progesterone due to reduced activity of the ovaries. Hypogonadism is classified into two types: primary hypogonadism (testicular failure) and central hypogonadism (hypothalamic-pituitary axis dysfunction). Other major causes of hypogonadism include autoimmune disorder, genetic disorder, severe infections, and liver and kidney diseases. Generally, hormone and imaging tests are used to diagnose hypogonadism.
According to the Boston University School of Medicine, around 4 million to 5 million men in the U.S. were affected with hypogonadism in 2003. The incidence of hypogonadism in men aged between 40 years and 69 years in the country is around 481,000 new cases per year. According to the European Male Aging Study, the prevalence of late onset hypogonadism in men aged between 40 and 79 was 2.1% in 2016. Studies suggest that hypogonadism in adult men is often underdiagnosed and undertreated and only 5%. According to the Urology Care Foundation, hypogonadism is a chronic condition which would require lifelong treatment. The treatment for hypogonadism depends on the cause and concern about fertility and includes treatment such as hormone replacement therapy or assisted reproduction.
Men with heart disease, HIV, COPD, or renal disease have high prevalence of hypogonadism. Factors such as rising prevalence of type 2 diabetes and obesity further increase the incidence of hypogonadism. Growth of the global hypogonadism treatment market is attributed to rise in geriatric population, increase in infertility, and improved diagnosis. However, growing concerns about the potential side effects, availability of generic drugs, and preference for other natural hormonal boosters and supplements are likely to hamper the growth of the hypogonadism treatment market. Increasing awareness, awaiting approvals for new generation drugs in pipeline, and technological advancements present significant opportunities in the hypogonadism treatment market.
The primary treatment option for hypogonadism is hormone replacement therapy. Based on product type, the market has been classified into testosterone replacement therapy, estrogen therapy, and progesterone therapy. Testosterone replacement therapy is the fastest growing segment as hypogonadism is more prevalent in men. The segment is expected to hold major share of the global market during the forecast period.
Browse more detail information about this report visit at at https://www.transparencymarketresearch.com/hypogonadism-treatment-market.html
In terms of mode of administration, the hypogonadism treatment market has been broadly classified into transdermal patch, topical gel, buccal tablets, implantable pellet, intramuscular injections, and oral tablets. Transdermal patch followed by topical gels are anticipated to be the fastest growing segments as these provide steady route of administration and are easily modifiable over a short period of time. The oral and buccal tablets segments are anticipated to experience sluggish growth during the forecast period due to high side effects and liver diseases.
Based on the distribution channel they are segmented into hospital pharmacies, retail pharmacies and others. The major market share for the hypogonadism treatment market is for the retail pharmacies segment and is anticipated to rule the market during the forecast period as continuous long term treatment is required for the hypogonadism patient.
In terms of region, the global hypogonadism treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the largest market for hypogonadism treatment, accounting for more than half of the market share due to the factors such as increased adoption of newer highly advanced products, rising awareness about hormonal disorder including various treatment options available, and advancing health care infrastructure. However, Asia Pacific is anticipated to be the fastest growing market during the forecast period due to increasing urbanization and rise in the patient population.
Key players in the global hypogonadism treatment market are Bayer AG, Abbott Laboratories, Inc., Merck Serono, Sanofi, Merck & Co., Inc., Actavis, Inc., AbbVie Inc., AstraZeneca plc, Teva Pharmaceutical Industries Ltd., Endo International plc, Ferring Holding S.A., and Laboratoires Genevrier.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Request Brochure of this report visit at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30392&source=atm
The study is a source of reliable data on: Market segments and sub-segments Market trends and dynamics Supply and demand Market size Current trends/opportunities/challenges Competitive landscape Technological breakthroughs Value chain and stakeholder analysis
The regional analysis covers: North America (U.S. and Canada) Latin America (Mexico, Brazil, Peru, Chile, and others) Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg) Eastern Europe (Poland and Russia) Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand) Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industrys value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report: A complete backdrop analysis, which includes an assessment of the parent market Important changes in market dynamics Market segmentation up to the second or third level Historical, current, and projected size of the market from the standpoint of both value and volume Reporting and evaluation of recent industry developments Market shares and strategies of key players Emerging niche segments and regional markets An objective assessment of the trajectory of the market Recommendations to companies for strengthening their foothold in the market
Note:Although care has been taken to maintain the highest levels of accuracy in TMRs reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Request For Discount On This Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=30392&source=atm
See the rest here:
Hypogonadism Treatment Market : Opportunities, Demand and Forecasts, 2017-2025 - Rapid News Network
- What is Male Hypogonadism? Learn Hormone.org's ... [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- Prevalence, Diagnosis and Treatment of Hypogonadism in ... [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- Hypogonadism: Types, Causes, & Symptoms Healthline [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- Hypogonadism - Wikipedia, the free encyclopedia [Last Updated On: May 4th, 2015] [Originally Added On: May 4th, 2015]
- Hypogonadotropic hypogonadism - Wikipedia, the free ... [Last Updated On: May 12th, 2015] [Originally Added On: May 12th, 2015]
- Male hypogonadism Tests and diagnosis - Mayo Clinic [Last Updated On: May 25th, 2015] [Originally Added On: May 25th, 2015]
- Male hypogonadism Symptoms - Mayo Clinic [Last Updated On: May 29th, 2015] [Originally Added On: May 29th, 2015]
- Male hypogonadism: Symptoms and treatment [Last Updated On: June 13th, 2015] [Originally Added On: June 13th, 2015]
- Low Testosterone in Men | Hypogonadism [Last Updated On: June 19th, 2015] [Originally Added On: June 19th, 2015]
- hypogonadism | pathology | Britannica.com [Last Updated On: July 23rd, 2015] [Originally Added On: July 23rd, 2015]
- Hypergonadotropic hypogonadism - Wikipedia, the free ... [Last Updated On: August 1st, 2015] [Originally Added On: August 1st, 2015]
- Hypogonadism | Disorders | Knowledge Base [Last Updated On: September 14th, 2015] [Originally Added On: September 14th, 2015]
- Male Hypogonadism - Cleveland Clinic [Last Updated On: October 7th, 2015] [Originally Added On: October 7th, 2015]
- Male hypogonadism Causes - Mayo Clinic [Last Updated On: October 13th, 2015] [Originally Added On: October 13th, 2015]
- Association of hypogonadism with vitamin D status: the ... [Last Updated On: February 15th, 2016] [Originally Added On: February 15th, 2016]
- What Is Low Testosterone? - Male Hypogonadism Symptoms and ... [Last Updated On: February 27th, 2016] [Originally Added On: February 27th, 2016]
- Hypogonadism | University of Maryland Medical Center [Last Updated On: March 11th, 2016] [Originally Added On: March 11th, 2016]
- Male Hypogonadism | Uroweb [Last Updated On: March 21st, 2016] [Originally Added On: March 21st, 2016]
- Hypogonadism | Conditions & Treatments | UCSF Medical Center [Last Updated On: March 29th, 2016] [Originally Added On: March 29th, 2016]
- Hypogonadism - Medscape [Last Updated On: March 29th, 2016] [Originally Added On: March 29th, 2016]
- Treatment Options for Hypogonadism Healthline [Last Updated On: March 29th, 2016] [Originally Added On: March 29th, 2016]
- Hypogonadism Causes Infertility. Learn how to detect and ... [Last Updated On: May 6th, 2016] [Originally Added On: May 6th, 2016]
- Hypogonadism - FPnotebook.com [Last Updated On: May 6th, 2016] [Originally Added On: May 6th, 2016]
- Testosterone treatment of male hypogonadism - UpToDate [Last Updated On: May 6th, 2016] [Originally Added On: May 6th, 2016]
- EFPIA - Hypogonadism [Last Updated On: May 6th, 2016] [Originally Added On: May 6th, 2016]
- Hypogonadism - RightDiagnosis.com [Last Updated On: May 6th, 2016] [Originally Added On: May 6th, 2016]
- Hypogonadotropic hypogonadism - Wikipedia, the free encyclopedia [Last Updated On: May 6th, 2016] [Originally Added On: May 6th, 2016]
- Hypogonadism Symptoms, Diagnosis, Treatments and Causes ... [Last Updated On: June 1st, 2016] [Originally Added On: June 1st, 2016]
- Compare 37 Hypogonadism, Male Medications | Drugs.com [Last Updated On: July 3rd, 2016] [Originally Added On: July 3rd, 2016]
- Male Hypogonadism - Genitourinary Disorders - Merck ... [Last Updated On: July 10th, 2016] [Originally Added On: July 10th, 2016]
- Hypogonadism - Medscape Reference [Last Updated On: July 15th, 2016] [Originally Added On: July 15th, 2016]
- Hypogonadism and Hypogonadism Resources - What is ... [Last Updated On: July 17th, 2016] [Originally Added On: July 17th, 2016]
- Testosterone Deficiency, Hypogonadism | Froedtert Hospital ... [Last Updated On: July 17th, 2016] [Originally Added On: July 17th, 2016]
- Hypogonadism diagnosis - history - Endobible [Last Updated On: July 17th, 2016] [Originally Added On: July 17th, 2016]
- Hypogonadism - Risks, Symptoms and Leading Causes | Treato [Last Updated On: July 17th, 2016] [Originally Added On: July 17th, 2016]
- Lipocine - Hypogonadism [Last Updated On: July 17th, 2016] [Originally Added On: July 17th, 2016]
- Hypogonadism - Definition, Causes, Symptoms and Treatment [Last Updated On: July 17th, 2016] [Originally Added On: July 17th, 2016]
- HIV and Testosterone Deficiency - verywell.com [Last Updated On: July 17th, 2016] [Originally Added On: July 17th, 2016]
- Hypogonadism - UT Medical Center [Last Updated On: July 17th, 2016] [Originally Added On: July 17th, 2016]
- Diagnosis of Hypogonadism: Clinical Assessments and ... [Last Updated On: July 20th, 2016] [Originally Added On: July 20th, 2016]
- Hypogonadism - Wikipedia [Last Updated On: October 25th, 2016] [Originally Added On: October 25th, 2016]
- Hypergonadotropic hypogonadism - Wikipedia [Last Updated On: November 26th, 2016] [Originally Added On: November 26th, 2016]
- Hypogonadism No Moustache! No Beard [Last Updated On: December 7th, 2016] [Originally Added On: December 7th, 2016]
- You & Your Hormones | Endocrine conditions | Male hypogonadism [Last Updated On: December 29th, 2016] [Originally Added On: December 29th, 2016]
- Posters to Be Presented at the Endocrine Society 2017 Annual Meeting - Business Wire (press release) [Last Updated On: February 8th, 2017] [Originally Added On: February 8th, 2017]
- Low Testosterone Products Litigation - US Recall News (press release) [Last Updated On: February 10th, 2017] [Originally Added On: February 10th, 2017]
- Testosterone therapy provides protection against cardiovascular disease in men with low testosterone - Science Daily [Last Updated On: February 15th, 2017] [Originally Added On: February 15th, 2017]
- Hypogonadism in Reproductive Years - Renal and Urology News [Last Updated On: February 15th, 2017] [Originally Added On: February 15th, 2017]
- Latest Research Predicts Endocrinology Drugs Market in Nascent Stage set for advancing growth by 2021 - Satellite PR News (press release) [Last Updated On: February 16th, 2017] [Originally Added On: February 16th, 2017]
- Testosterone therapy may help prevent heart disease - Bel Marra Health [Last Updated On: February 17th, 2017] [Originally Added On: February 17th, 2017]
- Studies show testosterone offers little benefits to aging men - Ars Technica [Last Updated On: February 21st, 2017] [Originally Added On: February 21st, 2017]
- New studies fail to change 'unfavorable balance' of risks/benefits of testosterone supplements - MinnPost [Last Updated On: February 23rd, 2017] [Originally Added On: February 23rd, 2017]
- Testosterone treatment and coronary artery plaque volume in older men with low testosterone - Pharmacy Today, American Pharmacists Association,... [Last Updated On: February 24th, 2017] [Originally Added On: February 24th, 2017]
- A study to evaluate the prevalence of hypogonadism in Indian males with Type-2 diabetes mellitus. - UroToday [Last Updated On: February 27th, 2017] [Originally Added On: February 27th, 2017]
- 8 things you need to know about testosterone and 'the male menopause' - Netdoctor [Last Updated On: February 28th, 2017] [Originally Added On: February 28th, 2017]
- Antares Pharma Announces FDA Acceptance of New Drug Application for Quickshot Testosterone - P&T Community [Last Updated On: February 28th, 2017] [Originally Added On: February 28th, 2017]
- Increased Plaque Volume on CCTA in Older Men Who Use Testosterone Gel - Diagnostic Imaging [Last Updated On: March 1st, 2017] [Originally Added On: March 1st, 2017]
- Denosumab is really effective in the treatment of osteoporosis secondary to hypogonadism in prostate carcinoma ... - UroToday [Last Updated On: March 2nd, 2017] [Originally Added On: March 2nd, 2017]
- Declining libido? This may be the cause - Bel Marra Health [Last Updated On: March 3rd, 2017] [Originally Added On: March 3rd, 2017]
- USADA notifies Ben Rothwell of potential anti-doping violation, putting UFC 211 status in jeopardy - MMAjunkie.com [Last Updated On: March 8th, 2017] [Originally Added On: March 8th, 2017]
- Family strength helps Brandon Ramirez persevere - Progress Index [Last Updated On: March 11th, 2017] [Originally Added On: March 11th, 2017]
- TRT and heart health: Conflicting findings published - ModernMedicine [Last Updated On: March 18th, 2017] [Originally Added On: March 18th, 2017]
- Efficacy and safety of testosterone replacement gel for treating hypogonadism in men: Phase III open-label studies. - UroToday [Last Updated On: March 19th, 2017] [Originally Added On: March 19th, 2017]
- Testosterone therapy has positive effects on anthropometric measures, metabolic syndrome components (obesity, lipid ... - UroToday [Last Updated On: March 19th, 2017] [Originally Added On: March 19th, 2017]
- JAMA confirms DTC drove 'Low-T' craze - BioPharma Dive [Last Updated On: March 23rd, 2017] [Originally Added On: March 23rd, 2017]
- Ads for low-testosterone treatments benefit sales but not necessarily health - Science Daily [Last Updated On: March 28th, 2017] [Originally Added On: March 28th, 2017]
- Sport and male sexuality. - UroToday [Last Updated On: March 28th, 2017] [Originally Added On: March 28th, 2017]
- A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management. - UroToday [Last Updated On: April 3rd, 2017] [Originally Added On: April 3rd, 2017]
- Infertility - Causes - NHS Choices [Last Updated On: April 7th, 2017] [Originally Added On: April 7th, 2017]
- Recent research: Male hypogonadism - strategic assessment and ... - WhaTech [Last Updated On: April 15th, 2017] [Originally Added On: April 15th, 2017]
- Testosterone level and endothelial dysfunction in patients with vasculogenic erectile dysfunction. - UroToday [Last Updated On: April 18th, 2017] [Originally Added On: April 18th, 2017]
- XOMA Announces Positive Results from its Phase 2 Proof-Of ... - Yahoo Finance [Last Updated On: April 24th, 2017] [Originally Added On: April 24th, 2017]
- Impact of metabolic status on the association of serum vitamin D with hypogonadism and lower urinary tract symptoms ... - UroToday [Last Updated On: April 25th, 2017] [Originally Added On: April 25th, 2017]
- Global Male Hypogonadism Market, 20162024: Type. Size, Share, Trends & Forecast Report - MilTech [Last Updated On: April 26th, 2017] [Originally Added On: April 26th, 2017]
- Global Male Hypogonadism Market, 20162024: Type. Size, Share, Trends & Forecast Report - satPRnews (press release) [Last Updated On: April 27th, 2017] [Originally Added On: April 27th, 2017]
- Aytu BioScience to Provide Fiscal Third Quarter 2017 Business Update - PR Newswire (press release) [Last Updated On: May 3rd, 2017] [Originally Added On: May 3rd, 2017]
- What's in the Cards for Repros (RPRX) this Earnings Season? - Zacks.com [Last Updated On: May 5th, 2017] [Originally Added On: May 5th, 2017]
- Testosterone Replacement Therapy May Protect Against Stroke, Heart Attack in Hypogonadism - Endocrinology Advisor [Last Updated On: May 5th, 2017] [Originally Added On: May 5th, 2017]
- In Hypogonadism, Stroke May Be Prevented With Testosterone Replacement Therapy - Neurology Advisor [Last Updated On: May 9th, 2017] [Originally Added On: May 9th, 2017]
- AYTU BIOSCIENCE, INC. (OTCMKTS:AYTU) Files An 8-K Entry into a Material Definitive Agreement - Market Exclusive [Last Updated On: May 10th, 2017] [Originally Added On: May 10th, 2017]